Details for 2012816132
Up to date per 03.04.2026
Actions
Details for 2012816132
Granted/Registered
European Patent
15.10.2014 A
27.06.2018 B1
07.12.2011
US
201161567675 P
C12N 15/09 20060101AFI20130625BHEP
Owner
Glenmark Pharmaceuticals S.A.Chemin de la Combeta, 5 2300 La Chaux-de-FondsCH
Representative
Representative
Kliment & Henhapel Patentanwälte OGGonzagagasse 151010 WienAT
Inventor
LUESCHER, DanielChemin de la Combeta 5 CH-2300 La Chaux-de-FondsCH
AEBISCHER-GUMY, ChristelChemin de la Combeta 5 CH-2300 La Chaux-de-FondsCH
MORETTI, PierreChemin de la Combeta 5 2300 La Chaux-de-FondsFR
BERTSCHINGER, MartinChemin de la Combeta 5 2300 La Chaux-de-FondsDE
Information about Fees